Evidence map›Paper›PMID 36951981›Full record

ArticleKnee surgery, sports traumatology, arthroscopy : official journal of the ESSKA2023

An implantable shock absorber yields an 85% survival-from-arthroplasty rate through 5 years in working-age patients with medial compartment knee osteoarthritis.

Andreas H Gomoll, David R Diduch, David C Flanigan, Anil S Ranawat, Konrad Slynarski, Jacek Walawski, Dennis C Crawford

Abstract readMulticenter Study
PubMed Publisher
In one paragraph

Article in Knee surgery, sports traumatology, arthroscopy : official journal of the ESSKA, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Surgical treatments of bone marrow lesions.Journal of experimental orthopaedics · 2026
    Review
  2. Article
  3. Implantable Shock Absorber: Breakthrough or Hype?Current reviews in musculoskeletal medicine · 2026
    Review
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 6 institutions in 2 countries.

Andreas H GomollHospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA. gomolla@hss.edu.ORCID http://orcid.org/0000-0001-8600-5301
David R DiduchDepartment of Orthopaedic Surgery, University of Virginia, Charlottesville, VA, USA.
David C FlaniganWexner Medical Center & Department of Orthopaedic Surgery, Ohio State University, Columbus, OH, USA.
Anil S RanawatHospital for Special Surgery, 535 East 70th Street, New York, NY, 10021, USA.
Konrad SlynarskiSlynarski Knee Clinic, Warsaw, Poland.
Jacek WalawskiŻagielMed Hospital, Lublin, Poland.
Dennis C CrawfordDepartment of Orthopedics & Rehabilitation, Oregon Health & Science University, Portland, OR, USA.
Hospital for Special Surgery · USInstitute of Physiology and Pathology of Hearing · PLLublin Oncology Center · PLOregon Health & Science University · USThe Ohio State University Wexner Medical Center · USUniversity of Virginia · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeTo evaluate the 5-year rate of survival without undergoing arthroplasty or high tibial osteotomy (HTO) in subjects with mild-to-moderate medial compartment knee osteoarthritis (OA) who were treated with an implantable shock absorber (ISA) system.

methodsThree prospective, sequential, multicenter, international, single-arm clinical trials were conducted comprising subjects who received an ISA for symptomatic medial knee OA after failing ≥ 6 months of conservative therapy. Study outcomes were analyzed cumulatively and by enrollment group when all subjects' follow-up data exceeded the 2-year threshold after ISA implantation. Primary outcome was survival rate without conversion to arthroplasty/HTO. Secondary outcomes were changes in Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain and function scores after ISA implantation.

resultsAll 171 enrolled subjects (age 51 ± 9 years, body-mass index 28.5 ± 3.5 kg/m

conclusionsIn younger patients with mild-to-moderate symptomatic medial compartment knee OA, implantation of the ISA device resulted in a 5-year survival rate of 85% from undergoing arthroplasty or HTO. The ISA system may be an effective treatment option for working-age patients with medial knee OA who are not candidates for or do not desire more invasive surgical approaches. LEVEL OF EVIDENCE: II.

Indexed as

Arthroplasty, Replacement, KneeOsteoarthritis, KneeAdultFemaleHumansKnee JointMaleMiddle AgedPainProspective StudiesRetrospective StudiesTibiaTreatment OutcomeFunctional outcomesImplantable shock absorberMedial compartment knee osteoarthritisSurvivorshipTotal knee arthroplastyWOMAC pain and function score

Identifiers

PMID36951981
OpenAlexW4360599887

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.